At Barts-MS we #ThinkSocial. We hypothesise that MS is like other chronic diseases and is affected by social capital and the social determinants of disease (SDOD). In short, if you have high social capital you will have a better outcome and if you have a favourable social profile you will also do better regardless of the type of MS you have. We are now actively researching these issues and have...

ECTRIMS 2018… here we go again!

In little over 2 weeks’ time, the MS professional community will travel to Berlin for the 34th ECTRIMS meeting. It’s the largest European conference focusing on MS research and treatment, and is attended by MS healthcare professionals, companies, researchers and charities.   Similar to previous years, the Barts-MS team are keen to get some of this new research out to you as quickly as...



Recent Posts

Recent Comments